New Key Statistics Module, Z-Score and F-Score
NAS:HBIO Key Ratios
Market Cap $ M | 98.57 |
Enterprise Value $ M | 138.82 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | 18.08 |
Price/Book | 1.51 |
Price/Sales | 0.99 |
Price/Free Cash Flow | 452.00 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 97.00 |
EPS (TTM) $ | -0.33 |
Beneish M-Score | -3.12 |
10-y EBITDA Growth Rate % | -1.80 |
5-y EBITDA Growth Rate % | -12.40 |
y-y EBITDA Growth Rate % | -135.00 |
EV-to-EBIT | -13.60 |
EV-to-EBITDA | -45.76 |
PEG | -- |
Shares Outstanding M | 43.62 |
Net Margin (%) | -14.57 |
Operating Margin % | -5.64 |
Pre-tax Margin (%) | -13.67 |
Quick Ratio | 0.91 |
Current Ratio | 2.06 |
ROA % (ttm) | -10.62 |
ROE % (ttm) | -20.42 |
ROIC % (ttm) | -4.75 |
Dividend Yield % | -- |
Altman Z-Score | -0.09 |
HBIO Number of Guru Trades
HBIO Volume of Guru Trades
Gurus Latest Trades with NAS:HBIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:HBIO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Harvard Bioscience Inc Insider Transactions
No Available Data
News about NAS:HBIO
Total 0- 1